1. Home
  2. INDP vs RAYA Comparison

INDP vs RAYA Comparison

Compare INDP & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • RAYA
  • Stock Information
  • Founded
  • INDP 2000
  • RAYA 2019
  • Country
  • INDP United States
  • RAYA China
  • Employees
  • INDP N/A
  • RAYA N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • INDP Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • INDP Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • INDP 6.0M
  • RAYA 6.1M
  • IPO Year
  • INDP N/A
  • RAYA 2022
  • Fundamental
  • Price
  • INDP $2.60
  • RAYA $0.04
  • Analyst Decision
  • INDP Strong Buy
  • RAYA
  • Analyst Count
  • INDP 2
  • RAYA 0
  • Target Price
  • INDP $238.00
  • RAYA N/A
  • AVG Volume (30 Days)
  • INDP 14.7K
  • RAYA 60.5M
  • Earning Date
  • INDP 08-13-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • INDP N/A
  • RAYA N/A
  • EPS Growth
  • INDP N/A
  • RAYA N/A
  • EPS
  • INDP N/A
  • RAYA N/A
  • Revenue
  • INDP N/A
  • RAYA $30,300,360.00
  • Revenue This Year
  • INDP N/A
  • RAYA $20.95
  • Revenue Next Year
  • INDP N/A
  • RAYA N/A
  • P/E Ratio
  • INDP N/A
  • RAYA N/A
  • Revenue Growth
  • INDP N/A
  • RAYA 49.10
  • 52 Week Low
  • INDP $3.21
  • RAYA $0.04
  • 52 Week High
  • INDP $58.24
  • RAYA $3.35
  • Technical
  • Relative Strength Index (RSI)
  • INDP 18.83
  • RAYA 27.13
  • Support Level
  • INDP $6.26
  • RAYA $0.05
  • Resistance Level
  • INDP $6.65
  • RAYA $0.05
  • Average True Range (ATR)
  • INDP 0.76
  • RAYA 0.01
  • MACD
  • INDP -0.33
  • RAYA 0.06
  • Stochastic Oscillator
  • INDP 2.84
  • RAYA 13.00

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: